Sara Rummelhoff, NP

NPI: 1497277354
Total Payments
$1,126
2022 Payments
$226.37
Companies
15
Transactions
46
Medicare Patients
118
Medicare Billing
$10,905

Payment Breakdown by Category

Food & Beverage$1,126 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,126 46 100.0%

Top Paying Companies

Company Total Records Latest Year
AbbVie Inc. $243.41 8 $0 (2021)
GlaxoSmithKline, LLC. $186.38 9 $0 (2022)
UCB, Inc. $144.89 7 $0 (2021)
Alexion Pharmaceuticals, Inc. $141.06 2 $0 (2021)
Amgen Inc. $82.74 3 $0 (2022)
Takeda Pharmaceuticals U.S.A., Inc. $80.42 4 $0 (2022)
Lundbeck LLC $65.76 3 $0 (2022)
Daiichi Sankyo Inc. $35.19 2 $0 (2021)
AstraZeneca Pharmaceuticals LP $28.09 2 $0 (2021)
AMAG Pharmaceuticals, Inc. $25.33 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2022 $226.37 11 GlaxoSmithKline, LLC. ($128.41)
2021 $899.75 35 AbbVie Inc. ($243.41)

All Payment Transactions

46 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/19/2022 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $18.32 General
Category: IMMUNOLOGY
06/09/2022 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $21.20 General
Category: IMMUNOLOGY
04/26/2022 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $23.91 General
Category: IMMUNOLOGY
04/20/2022 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $22.38 General
Category: IMMUNOLOGY
04/18/2022 Horizon Therapeutics plc TEPEZZA (Drug) Food and Beverage In-kind items and services $19.48 General
Category: TEPEZZA
04/14/2022 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $21.85 General
Category: Bone Health
02/15/2022 Medtronic, Inc. POWEREASE INSTRUMENTS (Device) Food and Beverage In-kind items and services $12.03 General
Category: Enabling
02/11/2022 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $22.88 General
Category: IMMUNOLOGY
02/11/2022 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $19.72 General
Category: IMMUNOLOGY
02/10/2022 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $19.83 General
Category: INTERNAL MEDICINE
02/02/2022 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $24.77 General
Category: NEUROLOGY
12/15/2021 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $3.13 General
Category: ANTI-INFECTIVE
11/06/2021 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $16.67 General
11/04/2021 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $8.27 General
Category: Immunology
10/27/2021 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $120.00 General
10/25/2021 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $19.66 General
Category: IMMUNOLOGY
10/14/2021 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $23.42 General
Category: INTERNAL MEDICINE
10/13/2021 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $15.30 General
10/07/2021 Alexion Pharmaceuticals, Inc. Soliris (Drug) Food and Beverage In-kind items and services $21.06 General
Category: Immunology
09/20/2021 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $21.51 General
Category: IMMUNOLOGY
09/09/2021 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $4.94 General
Category: Immunology
09/01/2021 Takeda Pharmaceuticals U.S.A., Inc. GAMMAGARD (Biological) Food and Beverage In-kind items and services $14.62 General
Category: IMMUNOLOGY
08/30/2021 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $16.80 General
Category: IMMUNOLOGY
08/23/2021 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $11.42 General
08/19/2021 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $34.39 General
Category: Bone Health

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2020 4 118 139 $37,429 $10,905
Total Patients
118
Total Services
139
Medicare Billing
$10,905
Procedure Codes
4

All Medicare Procedures & Services

4 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2020 59 60 $16,082 $4,748 29.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 24 44 $8,560 $2,394 28.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 13 13 $7,169 $2,113 29.5%
99218 Hospital observation care, typically 30 minutes Facility 2020 22 22 $5,618 $1,650 29.4%

About Sara Rummelhoff, NP

Sara Rummelhoff, NP is a Nurse Practitioner healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2017. The National Provider Identifier (NPI) number assigned to this provider is 1497277354.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sara Rummelhoff, NP has received a total of $1,126 in payments from pharmaceutical and medical device companies, with $226.37 received in 2022. These payments were reported across 46 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,126).

As a Medicare-enrolled provider, Rummelhoff has provided services to 118 Medicare beneficiaries, totaling 139 services with total Medicare billing of $10,905. Data is available for 1 year (2020–2020), covering 4 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Stanford, CA
  • Active Since 07/12/2017
  • Last Updated 03/28/2023
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1497277354

Products in Payments

  • DALVANCE (Drug) $243.41
  • NUCALA (Biological) $186.38
  • Cimzia (Drug) $144.89
  • EVENITY (Biological) $82.74
  • ENTYVIO (Biological) $65.80
  • VYEPTI (Biological) $65.76
  • INJECTAFER (Drug) $35.19
  • FERAHEME (Drug) $25.33
  • STELARA (Biological) $23.22
  • OCREVUS (Biological) $22.82
  • Soliris (Drug) $21.06
  • TEPEZZA (Drug) $19.48
  • GAMMAGARD (Biological) $14.62
  • POWEREASE INSTRUMENTS (Device) $12.03

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Stanford